Overview
Properties
Constituents: 10% Trehalose, 1% Human serum albumin
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab83921 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: Use at an assay dependent concentration. Ab83921 can be used as a WB positive control in conjunction with ab84684. |
| SDS-PAGE | SDS-PAGE: Use at an assay dependent dilution. Migrates as a broad band between 15 and 16 kDa due to post-translation modifications, in particular glycosylation. |
Protein info
-
Alternative names
- BMP 7BMP-7Bmp7
- BMP7_HUMANBone morphogenetic protein 7Bone morphogenic protein 7Eptotermin alfaOP 1OP-1OP1Osteogenic protein 1
see all
modificationsSeveral N-termini starting at positions 293, 300, 315 and 316 have been identified by direct sequencing resulting in secretion of different mature forms (PubMed:17977014).
Target information above from: UniProt accession
P18075
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
BMP7 protein (Human) images
-
Anti-BMP7 antibody (ab84684) at 1/1 dilution +
BMP7 protein (Human) (ab83921) at 0.1 µg
Secondary
Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP), pre-adsorbed (ab97080) at 1/5000 dilution
developed using the ECL technique
Performed under reducing conditions.
Exposure time : 1 minute
References for BMP7 protein (Human) (ab83921)
ab83921 has not yet been referenced specifically in any publications.
